Gastrointestinal Cancer

Cancers of the gastrointestinal tract (GI) including esophagus, stomach, pancreas, bile duct, liver, colon, rectum and anus are a major healthcare burden and constitute the third leading cause of cancer related deaths in both men and women in the US. In the past decade, several therapeutic advances have led to better treatment options and improved outcomes for patients with these cancers. In order to maximize the benefits of this progress for every patient however, a comprehensive strategy that takes into account all aspects of care is crucial. The complexity involved in delivery of such care makes it necessary to have a team of specialists that can work together to provide each patient with the best possible treatment that is tailored to their individual situation. This is what we do best at the GI multimodality clinic at the James Graham Brown Cancer Center.

Our team includes specialists in surgical oncology, hepato-pancreatico-biliary (HPB) surgery, medical oncology, radiation oncology, interventional radiology as well as several other disciplines with specific interest and expertise in treating patients with GI and HPB cancers.  In addition to employing the most current, state of the art therapeutic standards, we endeavor to further stretch those boundaries and maximize benefits to our patients by way of cancer trials utilizing new and innovative medications, procedures and strategies. Our goal is to strive for excellence in every aspect of care that we provide in order to improve the overall outcomes and quality of life in all of our patients afflicted with GI & HPB diseases.

We believe that the trust placed in us by our patients deserves nothing less.

 

Members of the Gastrointestinal Cancer Team